User profiles for G. Maura

Gabriela Plasencia

Other name: Gabriela Maura
Clinical Associate Faculty, Department of Family Medicine & Community Health
Verified email at duke.edu
Cited by 202

[HTML][HTML] Oxytocin and socioemotional aging: Current knowledge and future trends

NC Ebner, GM Maura, K MacDonald… - Frontiers in Human …, 2013 - frontiersin.org
… were faster at labeling happy expressions than individuals carrying a G-allele [M = 1212
ms, SD … However, interestingly, greater recruitment of right ACC in individuals carrying a G-allele …

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases

…, K Kubota, ECC Lai, JE Martikainen, G Maura… - The Lancet …, 2018 - thelancet.com
Background The use of medications to treat attention deficit hyperactivity disorder (ADHD)
has increased, but the prevalence of ADHD medication use across different world regions is …

[HTML][HTML] Receptor-receptor interactions and microvesicle exchange as mechanisms modulating signaling between neurons and astrocytes

…, C Tortorella, M Marcoli, C Cervetto, G Maura… - …, 2023 - Elsevier
It is well known that astrocytes play a significant metabolic role in the nervous tissue, maintaining
the homeostasis of the extracellular space and of the blood-brain barrier, and providing …

Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban …

G Maura, PO Blotière, K Bouillon, C Billionnet… - Circulation, 2015 - Am Heart Assoc
Background— The safety and effectiveness of non–vitamin K antagonist (VKA) oral anticoagulants,
dabigatran or rivaroxaban, were compared with VKA in anticoagulant-naive patients …

Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers

TH De Boer, G Maura, M Raiteri, CJ De Vos… - …, 1988 - Elsevier
The neurochemical and autonomic pharmacological profile of l,2,3,4,10,14b-hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]
benzazepine (±)Org 3770) and the related …

[HTML][HTML] Exosomes from astrocyte processes: signaling to neurons

…, K Cortese, MC Gagliani, G Leo, G Maura… - Frontiers in …, 2019 - frontiersin.org
… The homogenate was centrifuged (5 min at 4C and 1,000 g) to remove nuclei and debris …
sucrose) and centrifuged for 5 min at 4C and 33,000 g. The layer between 2% and 6% (v/v) …

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K …

K Bouillon, M Bertrand, G Maura, PO Blotière… - The Lancet …, 2015 - thelancet.com
Background Patients with non-valvular atrial fibrillation who are receiving or have been
previously exposed to a vitamin K antagonist could be switched to a non-vitamin K-antagonist …

Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release

G Maura, M Raiteri - European journal of pharmacology, 1986 - Elsevier
… adult male Sprague-Dawley rats (200-250 g) was homogenized in 40 volumes of 0.32 M
sucrose buffered at pH 7.4 with phosphate. The homogenate was centrifuged (5 min, 1000 × …

Cortical cultures coupled to micro-electrode arrays: a novel approach to perform in vitro excitotoxicity testing

…, A Contestabile, M Nanni, L Bonzano, G Maura… - Neurotoxicology and …, 2012 - Elsevier
In vitro neuronal cultures exhibit spontaneous electrophysiological activity that can be
modulated by chemical stimulation and can be monitored over time by using Micro-Electrode …

Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.

G Maura, A Giardi, M Raiteri - Journal of Pharmacology and Experimental …, 1988 - ASPET
The effects of dopamine (DA) and other dopaminergic receptor agonists on the
depolarization-evoked release of endogenous glutamic acid (GLU) have been studied using …